Framingham, MA, United States of America

Guoyou Xu

This inventor holds 30 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Hepatitis C Inhibitors. Top assignee: Enanta Pharmaceuticals, Inc.. Active years: 2005-2021.

USPTO Granted Patents = 30 (Patent Applications = 1)

% Patents Active = 60.0

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 7.2

ph-index = 8

Forward Citations = 269(Granted Patents)

Location History:

Newton, MA (US) (2006 - 2008)
Auburndale, MA (US) (2005 - 2009)
Framingham, MA (US) (2009 - 2021)

Company Filing History:

30 out of 298

Enanta Pharmaceuticals, Inc.

patents

Years Active: 2005-2021

Loading Chart...

Areas of Expertise:

Hepatitis C

Macrocyclic Inhibitors

Quinoxalinyl Derivatives

Bile Acid Derivatives

Erythromycin Derivatives

Serine Protease Inhibitors

Fluoro Compounds

Oximyl Derivatives

Bicyclic Compounds

Polymorphic Forms

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947264 - Process for preparation of sulfonylurea bile acid derivatives (2021-03-16),

2. 10584145 - Process for preparation of sulfonylurea bile acid derivatives (2020-03-10),

3. 10364267 - Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof (2019-07-30),

4. 9526769 - Macrocylic oximyl hepatitis C protease inhibitors (2016-12-27),

5. 9242974 - Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives (2016-01-26),

6. 8962551 - Quinoxalinyl derivatives (2015-02-24),

7. 8927739 - Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives (2015-01-06),

8. 8921573 - Processes for the preparation of novel benzimidazole derivatives (2014-12-30),

9. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors (2014-08-19),

10. 8552162 - Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives (2013-10-08),

11. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors (2013-08-06),

12. 8268777 - Oximyl macrocyclic derivatives (2012-09-18),

13. 8268776 - Macrocylic oximyl hepatitis C protease inhibitors (2012-09-18),

14. 8236807 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors (2012-08-07),

15. 8193346 - Process for making macrocyclic oximyl hepatitis C protease inhibitors (2012-06-05),

Title: Guoyou Xu: Innovator in Sulfonylurea Bile Acid Derivatives

Introduction: Guoyou Xu, based in Framingham, MA, is a prominent inventor with an impressive portfolio of 30 patents. His contributions primarily revolve around the field of pharmaceutical sciences, focusing on the development of novel compounds with therapeutic potential.

Latest Patents: Among his latest innovations are patents related to the preparation of sulfonylurea bile acid derivatives. The first patent presents compounds of specific formulas, highlighting their utility as intermediates in synthesizing biologically active molecules. The second patent elaborates on processes for obtaining the same compounds, which are recognized for their role as FXR or TGR5 modulators. These innovative compounds aim to enhance treatment options through their pharmaceutical compositions.

Career Highlights: Guoyou Xu's career is marked by his significant role at Enanta Pharmaceuticals, Inc., where he has made valuable advancements in drug discovery and development. His expertise in synthesizing bile acid derivatives has led to promising developments in the pharmaceutical industry.

Collaborations: Throughout his career, Guoyou Xu has collaborated with notable professionals, including his coworkers Yat Sun Or and Zhe Wang. Their joint efforts have propelled innovative research and furthered the understanding of complex biochemical processes.

Conclusion: Guoyou Xu exemplifies the spirit of innovation in the pharmaceutical field, with his patents paving the way for novel treatments. His work at Enanta Pharmaceuticals, Inc. and fruitful collaborations position him as a key contributor to advancements in medicine, specifically in the area of bile acid derivatives and their therapeutic applications.